Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mark Tompkins

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Journal of Wildlife Diseases|November 8, 2014
In ovo and in vitro susceptibility of American alligators (Alligator mississippiensis) to avian influenza virus infectionBradley L Temple, John W Finger, Cheryl A Jones, et al.
Plos One|July 27, 2011
Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in miceMark R Soboleski, Jon D Gabbard, Graeme E Price, et al.
Influenza and Other Respiratory Viruses|October 9, 2024
Meeting Report From "Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID-19 Pandemic"Florian Krammer, Jacqueline M Katz, Othmar G Engelhardt, et al.
Journal of Virology|June 15, 2018
Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 ChallengeRaffael Nachbagauer, David Shore, Hua Yang, et al.
Virology|March 1, 2011
Comparison of the receptor binding properties of contemporary swine isolates and early human pandemic H1N1 isolates (Novel 2009 H1N1)Konrad C Bradley, Cheryl A Jones, S Mark Tompkins, et al.
Mabs|February 5, 2014
Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targetsKrista M McCutcheon, Julia Gray, Natalie Y Chen, et al.
NPJ Vaccines|December 22, 2017
Developing a platform system for gene delivery: amplifying virus-like particles (AVLP) as an influenza vaccineHuiling Wei, Zhenhai Chen, Andrew Elson, et al.
Frontiers in Immunology|November 6, 2023
Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine modelVasilis C Pliasas, Peter J Neasham, Maria C Naskou, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 14, 2016
Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunityLi Wang, Timothy Z Chang, Yuan He, et al.
Plos One|July 7, 2011
Avian influenza viruses infect primary human bronchial epithelial cells unconstrained by sialic acid α2,3 residuesChristine M Oshansky, Jennifer A Pickens, Konrad C Bradley, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Journal of Wildlife Diseases|November 8, 2014
In ovo and in vitro susceptibility of American alligators (Alligator mississippiensis) to avian influenza virus infectionBradley L Temple, John W Finger, Cheryl A Jones, et al.
Plos One|July 27, 2011
Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in miceMark R Soboleski, Jon D Gabbard, Graeme E Price, et al.
Influenza and Other Respiratory Viruses|October 9, 2024
Meeting Report From "Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID-19 Pandemic"Florian Krammer, Jacqueline M Katz, Othmar G Engelhardt, et al.
Journal of Virology|June 15, 2018
Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 ChallengeRaffael Nachbagauer, David Shore, Hua Yang, et al.
Virology|March 1, 2011
Comparison of the receptor binding properties of contemporary swine isolates and early human pandemic H1N1 isolates (Novel 2009 H1N1)Konrad C Bradley, Cheryl A Jones, S Mark Tompkins, et al.
Mabs|February 5, 2014
Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targetsKrista M McCutcheon, Julia Gray, Natalie Y Chen, et al.
NPJ Vaccines|December 22, 2017
Developing a platform system for gene delivery: amplifying virus-like particles (AVLP) as an influenza vaccineHuiling Wei, Zhenhai Chen, Andrew Elson, et al.
Frontiers in Immunology|November 6, 2023
Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine modelVasilis C Pliasas, Peter J Neasham, Maria C Naskou, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 14, 2016
Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunityLi Wang, Timothy Z Chang, Yuan He, et al.
Plos One|July 7, 2011
Avian influenza viruses infect primary human bronchial epithelial cells unconstrained by sialic acid α2,3 residuesChristine M Oshansky, Jennifer A Pickens, Konrad C Bradley, et al.
Pageof 10